← Leaderboards
Randall F Holcombe
University Of California Irvine
$5,463,874
Attributed
$7,530,583
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$18,357,157 · 11
By mechanism
P30$13,110,642 · 4
UG1$2,649,804 · 1
K24$1,378,909 · 1
R21$849,111 · 2
R03$303,409 · 1
M01$65,282 · 2
Top collaborators
- Jared Acoba2 shared
- Jeffrey Lee Berenberg2 shared
- Edward L. Nelson2 shared
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchMalignant NeoplasmsCancer PreventionUniversitiesCancer CenterClinical TrialsHawaiiProgramsFundingCharacteristicsResearch PersonnelCancer Center Support GrantMissionCancer ControlPatient CareBaseCancer BurdenAreaFacultyDesignEvaluationEthnic DiversityResource SharingCollaborations
Grant awards (38)
University of Hawaii Cancer Center CCSG$2,156,000
P30 · FY2020 · CA · contact PI
The Hawaii Minority/Underserved NCORP$1,276,438
UG1 · FY2020 · CA
Leadership, Planning and Evaluation$391,788
P30 · FY2020 · CA · contact PI
Developmental Funds$347,616
P30 · FY2020 · CA · contact PI
University of Hawaii Cancer Center CCSG$115,000
P30 · FY2020 · CA · contact PI
Community Outreach and Engagement$53,416
P30 · FY2020 · CA · contact PI
University of Hawaii Cancer Center CCSG$2,141,479
P30 · FY2019 · CA · contact PI
The Hawaii Minority/Underserved NCORP$1,373,366
UG1 · FY2019 · CA
Leadership, Planning and Evaluation$389,152
P30 · FY2019 · CA · contact PI
Developmental Funds$345,276
P30 · FY2019 · CA · contact PI
University of Hawaii Cancer Center CCSG$115,000
P30 · FY2019 · CA · contact PI
Community Outreach and Engagement$53,058
P30 · FY2019 · CA · contact PI
University of Hawaii Cancer Center CCSG$1,913,800
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$347,778
P30 · FY2018 · CA · contact PI
Developmental Funds$308,567
P30 · FY2018 · CA · contact PI
Community Outreach and Engagement$47,417
P30 · FY2018 · CA · contact PI
University of Hawaii Cancer Center CCSG$2,156,000
P30 · FY2017 · CA · contact PI
University of Hawaii Cancer Center CCSG$1,913,800
P30 · FY2016 · CA · contact PI
University of Hawaii Cancer Center CCSG$200,000
P30 · FY2016 · CA · contact PI
University of Hawaii Cancer Center CCSG$115,495
P30 · FY2016 · CA · contact PI
Neoadjuvant photodynamic immunomodulation for colon cancer$302,100
R21 · FY2011 · CA
Neoadjuvant photodynamic immunomodulation for colon cancer$298,246
R21 · FY2010 · CA
Patient-oriented Research: Colon CA & Cancer Immunology$91,205
K24 · FY2010 · CA · contact PI
Patient-oriented Research: Colon CA & Cancer Immunology$58,375
K24 · FY2010 · CA · contact PI
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON$172
M01 · FY2010 · RR · contact PI
Patient-oriented Research: Colon CA & Cancer Immunology$149,580
K24 · FY2009 · CA · contact PI
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON$65,110
M01 · FY2009 · RR · contact PI
Patient-oriented Research: Colon CA & Cancer Immunology$149,580
K24 · FY2008 · CA · contact PI
Patient-oriented Research: Colon CA & Cancer Immunology$148,562
K24 · FY2007 · CA · contact PI
A Phase 1 Study of CCI-779 in Combination with Imatnib *$248,765
R21 · FY2006 · CA · contact PI
Patient-oriented Research: Colon CA & Cancer Immunology$145,808
K24 · FY2006 · CA · contact PI
Wnt Signaling in IBD-Related Colon Cancer$151,909
R03 · FY2005 · DK
Patient oriented Research--Colon CA &Cancer Immunology$127,023
K24 · FY2005 · CA
Wnt Signaling in IBD-Related Colon Cancer$151,500
R03 · FY2004 · DK
Patient oriented Research--Colon CA &Cancer Immunology$126,987
K24 · FY2004 · CA
Patient oriented Research--Colon CA &Cancer Immunology$126,953
K24 · FY2003 · CA
Patient oriented Research--Colon CA &Cancer Immunology$126,921
K24 · FY2002 · CA
Patient oriented Research--Colon CA &Cancer Immunology$127,915
K24 · FY2001 · CA